Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
about
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort studyExternal quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology.Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serumPerspectives for the treatment of infections with Flaviviridae.Methodological issues in papers on IFN therapy: time for reappraisal.Treatment of chronic hepatitis C in haemophilia patients.Occurrence of genetic modifications in core, 5'UTR and NS5b of HCV associated with viral response to treatment.Review article: indicators and predictors of response to anti-viral therapy in chronic hepatitis C.Impact of ribavirin dose on retreatment of chronic hepatitis C patientsHepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.Update on the Development of Anti-Viral Agents Against Hepatitis C.Antiviral activity of Bacillus sp. isolated from the marine sponge Petromica citrina against bovine viral diarrhea virus, a surrogate model of the hepatitis C virus.Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays.African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians.Case selection for interferon treatment of hepatitis C.Clinical Profile and Response to Treatment with Pegylated Interferon α 2b and Ribavirin in Chronic Hepatitis C-A Reappraisal from a Tertiary Care Center in Northern India.Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor.Role of nitric oxide synthase genes in hepatitis E virus infection.Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy?Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C.Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy.Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C.Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment.Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.European guideline for the management of hepatitis B and C virus infections.IL-21 as a Predictor of Sustained Virologic Response in Patients with Chronic Hepatitis C Virus Infection.Treatment of hepatitis C virus infection in patients of northern India.Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan.
P2860
Q24799492-59D1A53C-A9A3-46FC-AE76-09BFEC7A61DFQ27471433-B55B1CBC-4835-4BF5-A1D7-1712788EAD90Q27472747-F5B9391B-E9D3-495A-B240-413C5B114878Q33812419-F442F27E-719B-48BF-BCF2-95EDF6049377Q33940500-C1EBF3B8-ED10-45C8-A05A-96303F38AD1FQ34107035-7AA76184-BAD6-45EB-8D7A-CEDD5D4D3B7CQ34896257-954AE953-FA43-4B71-99AE-1FD7A35341E5Q35086844-1E9F9CD0-4E86-4D57-8E37-6BE0F9CC6B53Q36049907-00755DDE-19E6-4FB5-9A80-E70DE40AA4C5Q37772959-31032C6C-2AB4-47E1-88DD-C989850286D7Q38584271-607D2F4D-8F8F-4DA6-9284-0C47F923D905Q39158546-9C84216C-841C-4197-AAEA-CB4DC4F0C3A0Q39459300-CE22D755-A988-49A1-B3C8-5445B8C7B2AFQ39573613-4D50D87E-9B48-41E1-82C1-32A3778FA64EQ40755017-26D9D37A-592B-4FF5-8F4B-E6DE436FB2B3Q41258033-F9AB8285-4D3F-4BB1-AB64-4AC2E9A40766Q42164795-ED9E28A0-19DD-417F-9592-E3476809F3B8Q42241233-1F578880-F92F-4554-A117-65DD8A2D7888Q42280440-1E5F76D5-4AAB-48F7-A137-476D38618BAAQ42983598-11BE1E59-9368-472E-BF11-8135151F2D0FQ42992776-5C4DCAE4-7CF4-42A1-942D-9D51675194F4Q43031370-9866F180-5032-43E4-AC0B-A481CCF65340Q43035645-CFAD8532-D3DD-44E5-8228-2DB1B80FDAE4Q43040005-F1B4DEC9-F497-4290-99AA-1CAACA37EEA3Q44118049-1928D9C8-2267-40C0-B111-16D39C7FB740Q45323960-570D4089-042C-4568-B2EE-B9156A5C40BEQ45601707-02E3E222-6426-4217-A71F-91A8EC8E6264Q50560812-FD8C3347-3F28-403A-9DB7-A2858BCC3C5CQ50580140-DF1FF197-851D-4725-9800-02CA115C7A33
P2860
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
@en
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
@nl
type
label
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
@en
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
@nl
prefLabel
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
@en
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
@nl
P2093
P1476
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
@en
P2093
C Castelnau
J P Benhamou
M Martinot-Peignoux
P Marcellin
S Erlinger
P304
P356
10.1016/S0168-8278(98)80006-8
P577
1998-08-01T00:00:00Z